Literature DB >> 32269699

Epstein-Barr virus-positive plasmacytoma in immunocompetent patients: a diagnostic dilemma.

Lu He1, Zhiwen Li1, Xiangshan Fan1, Qianyun Shi1, Hongyan Wu1, Jieyu Chen1.   

Abstract

By literature review, plasmacytomas arising in immunocompetent patients are rarely associated with Epstein-Barr virus (EBV) infection. EBV-positive plasmacytoma can cause a diagnostic dilemma as it may morphologically and phenotypically overlap with a clinically aggressive plasmablastic lymphoma (PBL). We reported the clinicopathologic and immunophenotypic findings of four patients with EBV-positive plasmacytomas (three cases of extramedullary plasmacytomas, one case of solitary plasmacytoma of bone) with immunocompetent status. These tumors were characterized by a diffuse proliferation of mature appearing plasma cells, which were diffusely positive for EBV encoded RNA (EBER) by in situ hybridization. All the four patients were alive with no evidence of disease at last follow-up. IJCEP
Copyright © 2020.

Entities:  

Keywords:  Epstein-Barr virus; immunocompetent; plasmablastic lymphoma; plasmacytoma

Year:  2020        PMID: 32269699      PMCID: PMC7137007     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  EBV-positive plasmacytoma of the submandibular gland--report of a rare case with molecular genetic characterization.

Authors:  Benedict Yan; Soo Yong Tan; Ee Xuan Yau; Siok Bian Ng; Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2011-03-26

Review 2.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

3.  Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection.

Authors:  Maria R Ambrosio; Giulia De Falco; Alessandro Gozzetti; Bruno J Rocca; Teresa Amato; Vasileios Mourmouras; Sara Gazaneo; Lucia Mundo; Veronica Candi; Pier P Piccaluga; Maria G Cusi; Lorenzo Leoncini; Stefano Lazzi
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

4.  Epstein-Barr virus-positive plasmacytoma in immunocompetent patients.

Authors:  Sanam Loghavi; Joseph D Khoury; L Jeffrey Medeiros
Journal:  Histopathology       Date:  2015-02-19       Impact factor: 5.087

5.  Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.

Authors:  Ruri Saito; Hiroyuki Abe; Akiko Kunita; Hiroharu Yamashita; Yasuyuki Seto; Masashi Fukayama
Journal:  Mod Pathol       Date:  2016-12-09       Impact factor: 7.842

6.  Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

Authors:  Junichi Kiyasu; Hiroaki Miyoshi; Akie Hirata; Fumiko Arakawa; Ayako Ichikawa; Daisuke Niino; Yasuo Sugita; Yuji Yufu; Ilseung Choi; Yasunobu Abe; Naokuni Uike; Koji Nagafuji; Takashi Okamura; Koichi Akashi; Ryoichi Takayanagi; Motoaki Shiratsuchi; Koichi Ohshima
Journal:  Blood       Date:  2015-08-03       Impact factor: 22.113

7.  Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV.

Authors:  Sheng-Tsung Chang; Yung-Liang Liao; Chin-Li Lu; Shih-Sung Chuang; Chin-Yang Li
Journal:  Am J Clin Pathol       Date:  2007-08       Impact factor: 2.493

8.  Unusual coexistence of extramedullary plasmacytoma and nasopharyngeal carcinoma in nasopharynx.

Authors:  Ri-Chang Du; Hai-Nan Li; Wei Huang; Xiao-Ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2015-09-17       Impact factor: 2.644

9.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

Authors:  Sanam Loghavi; Khaled Alayed; Tariq N Aladily; Zhuang Zuo; Siok-Bian Ng; Guilin Tang; Shimin Hu; C Cameron Yin; Roberto N Miranda; L Jeffrey Medeiros; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2015-06-10       Impact factor: 17.388

10.  Epstein-Barr virus-positive ileal extraosseous plasmacytoma containing plasmablastic lymphoma components with CD20-positive lymph node involvement.

Authors:  Makoto Saito; Masanobu Morioka; Ko Izumiyama; Akio Mori; Tatsuro Irie; Masanori Tanaka; Yoshihiro Matsuno
Journal:  Int J Gen Med       Date:  2012-08-23
  10 in total
  1 in total

1.  Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.

Authors:  Ting Zhou; Jinjun Cheng; Jeremiah Karrs; Theresa Davies-Hill; Svetlana D Pack; Liqiang Xi; Manoj Tyagi; Jung Kim; Elaine S Jaffe; Mark Raffeld; Stefania Pittaluga
Journal:  Am J Surg Pathol       Date:  2022-06-01       Impact factor: 6.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.